Journal of Surgery
Some Aspects of the Surgical and Endoscopic Treatment of Tuberculosis in Russia
Department of Pathology, People’s Friendship University of Russia, Russian Federation, Russia
*Address for Correspondence:Jargin SV, Department of Pathology, People’s Friendship University of Russia, Clementovski per 6-82, 115184 Moscow, Russia, Tel: 7 495 9516788; Email: firstname.lastname@example.org
Submission: 20-03-2021; Accepted: 22-04-2021; Published: 26-04-2021
Copyright: © 2021 Jargin SV. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
After the introduction of efficient drug therapy, the surgical treatment of tuberculosis (Tb) has been partly abandoned in many parts of the world. The priority of Russia in the field of Tb surgery was pointed out. An overview of literature on the surgical treatment and bronchoscopy in Tb is provided here. Despite the lack of reliable clinical trial data on efficacy and safety of adjunctive surgical therapy, some countries of the former Soviet Union continue to perform numerous lung resections. Tuberculoma has been one of the most frequent indications for lung surgery in Tb patients, which is generally at variance with the international practice. Besides, the use of bronchoscopy in Tb is briefly overviewed. In conclusion, some papers containing questionable recommendations have remained without due commentaries, so that a persistence of suboptimal practices or reversion to them is not excluded.
Tuberculosis; Surgery; Lung resection; Bronchoscopy; Russia
After the introduction of efficient drug therapy in the 1950-1960s, the surgical treatment of tuberculosis (Tb) has been partly abandoned in many parts of the world. The role of surgery remains controversial [1,2]. The priority of Russia in the field of Tb surgery was pointed out [3,4]. This achievement has been largely associated with the name of Mikhail Perelman. In 1998 he became director of the Institute for Phthisiopulmonology at the I.M. Sechenov Moscow Medical Academy and chief phthisiologist of the Health Ministry; in the following year he became editor in chief of Tuberk. Bolezn. Legk. (Tuberculosis and Lung Diseases), the leading Russian specialist journal. It was the time when World Health Organization (WHO) promoted the directly observed treatment, short course (DOTS) program in Russia. Perelman called this WHO program absurd, insisting that Tb should be treated surgically .
Materials and Methods
This article is a commentary based on the mini-review predominantly of Russian-language professional literature that is insufficiently known and partly unavailable outside the former Soviet Union (SU). Where necessary, comparisons with the foreign literature are made. The search of international literature was performed using PubMed. Russian-language professional publications were searched in the Internet and the electronic database eLibrary.Ru. Apart from the analysis of literature, this commentary is based on the observations by the author, who entered the I.M. Sechenov Medical University (named Institute at that time) in 1973, later practiced at the same and other academic and clinical institutions in Moscow.
From 1973 through 1987, 285,000 patients with pulmonary Tb were operated on in the former Soviet Union (SU), in 1987 – 26,000, while 85% of the operations were lung resections . In the period 1986-1988, 17,000-18,000 operations for pulmonary Tb were performed in Russia yearly only in specialized tuberculosis hospitals . In 2003, 10,479 surgeries were performed in Russia for respiratory Tb, which was deemed “extremely insufficient” . In 2006, 12,286 operations were carried out for pulmonary Tb including 9300 (75.7%) lobectomies and other resections as well as 399 (3.2%) pneumonectomies . According to another report, the forms of Tb most frequently treated by resections and pneumonectomies were cavitary Tb (52.2%) and tuberculoma (43.9%) .The abovenamed surgeries were performed and recommended also for patients with inactive post-tuberculous fibrosis including cases with sparse symptoms . At the same time, surgeries were performed in the active phase of Tb. In some provinces (Kemerovo, Chelyabinsk, Mordovia), 25-40% of patients with destructive Tb were operated on . At the time of initial Tb diagnosis, an operation was deemed reasonable in 15- 20% of patients . According to another paper by the same authors, indications for surgery were found in 20-30% of patients at the initial diagnosis and/or among cases of active Tb .In Yekaterinburg and surrounding province (2006-2008), indications for surgery were determined in 1784 from 4402 (40.5%) patients with pulmonary Tb while 1079 (24.5%) were operated on. Among reasons of the comparatively “low” surgery rate were the patients’ non-compliance and unavailability . In the international literature, corresponding figures are generally lower e.g. <5% of pulmonary Tb patients were supposed to require surgery . The same percentage is given in the reviews [14,15]. The topic of Tb surgery may become more relevant due to the multidrug resistance. According to a current estimate from Russia, the need for surgery has increased from 5% to 15% over the last twenty years . However, the recent systematic review and metaanalysis concluded that, compared with chemotherapy alone, the survival benefit of pulmonary resection combined with chemotherapy is not significant, although the quality of data was deemed “relatively poor” . According to another metaanalysis, partial lung resection, but not pneumonectomy, was associated with improved treatment success in multidrug-resistant Tb. It was not excluded, however, that “healthier” patients were preferentially chosen for surgery, leading to a bias. The confounding by indication, as patients most likely to benefit are selected for the treatment, has been a limitation in many studies . Despite the lack of reliable clinical trial data on efficacy and safety of adjunctive surgical treatment, some countries of the former SU continued to perform a high number of lung resections . A summary of indications from the World Health Organization (WHO) publication compiled under participation of Russian experts Drs. Dmitriy Giller (cited below), Boris Kazenniy and Denis Krasnov is presented here Table 1,2 .
Apparently, the WHO document was influenced by the Russian experts, which is recognizable especially from Table 2 . There is an opinion that indications for surgery in Tb are rarely absolute . As for contraindications, they largely depend on the process extension, preservation of the cardiopulmonary function and the general state of heath [19,21,23]. The following contraindications for elective surgery of pulmonary Tb (including multidrug-resistant Tb) are listed in the WHO publication : Extensive cavitary lesions of both lungs; forced expiratory volume in 1 sec <1.5 L for lobectomy and < 2.0 L for pneumonectomy; pulmonary-heart failure III-IV (functional classification of the New York Heart Association); body mass index up to 40-50% of the normal range; active bronchial Tb; severe co-morbidity . Tuberculoma (>2 cm, also in children) has been generally regarded as an indication for surgery by Giller and associates [25,26]. The same experts designated fibrocavitary Tb as an absolute indication for surgery . Tuberculomas >1 cm were routinely operated on also without preceding anti-Tb therapy [27-29], which is generally at variance with the international practice [18,30]. There has been an opinion since the 1950s that potential instability of tuberculoma does not generally justify thoracic surgery and that asymptomatic patients with an unchanging solid focus do not require treatment. Tuberculoma as an indication for pulmonary resection was seen differently from other forms of Tb where surgical risks could in some cases be justified by a poorer prognosis . Nonetheless, tuberculoma was the most frequent indication for lung surgery in Tb patients at the Moscow I.M. Sechenov Medical Academy (44.2%) , while at other institutions this percentage reached 50-80% . In particular, tuberculoma has been the most frequent indication for surgery among adolescent Tb patients . Children were routinely operated for tuberculomas, non-specific inflammatory, fibrotic lesions and bronchiectasis ; more references are in the preceding review . Bilateral resections were performed in various Tb forms including solitary tuberculomas on both sides [34-36]. A study from the above-mentioned Institute for Phthisiopulmonology reported 771 lung surgeries, including 168 pneumonectomies, 181 lobectomies and bilobectomies, 180 smaller resections, performed in 700 Tb patients with drug resistance, up to 4 operations pro patient. Postoperative complications were observed in 100 cases (12.9%), fatal cases - 12 (1.5%) . Another example from the same institution: among 60 operated Tb patients (16 pneumonectomies, 24 lobectomies and smaller resections) the complication rate was 37%, mortality – 5%; 18.3% were discharged from the hospital with persisting complications .
Resections were performed for tuberculoma, infiltrative and cavitary Tb without preceding medical treatment or within one month after the diagnosis i.e. when the drug therapy could have been efficient [28,39]. In diabetics, it was recommended to operate tuberculoma after 2-5 months of medical therapy . The authors operated asymptomatic patients and recorded the 15.73% rate of postoperative complications . Apparently, complication rates have been sometimes underestimated due to limited follow-ups. Lung operations for Tb were performed and recommended also for aged patients with comorbidities [42-44]. Sokolov found indications for surgery in 210 from 289 (72.6%) aged Tb patients (50-73 years old) and operated on 180 (62.2%) of them, 144 operations being lung resections. Among the latter 144 patients, 93 (66.4%) had cavitary disease and 43 (30.8%) – tuberculoma. Reactivation of Tb early after surgery was noted in 8.6% of cases, fistula - 27.2 %, atelectasis or incomplete lung re-expansion - 20%, pneumonia - 5.7%, pleural empyema - 3.6%, other complications - 12.9%; 8 (5.7%) patients died after the surgery . Tuberculoma was the most common indication, and lobectomy – the most frequent modality in elderly Tb patients, whereas epidemiological considerations i.e. potential contagiousness was listed among arguments in favor of the surgical treatment . Statements of this kind can be found also in recent papers e.g.: “Surgery in patients with tuberculomas is recommended to reduce their infectiousness” . In the author’s opinion, it is unethical to subject a patient to a thoracic surgery just because he or she is potentially contagious. In any case, the patient must be comprehensively informed about potential benefits and risks so that he or she could make an independent decision according to the principle of informed consent.
Bilateral resections were performed in various Tb forms including solitary tuberculomas on both sides or tuberculoma and cancer [34-36,45-47]. Indications for a second lung surgery were found in 20- 37% of previously operated Tb patients . Postoperative relapses of Tb were regarded as indications for repeated surgeries up to “concluding pneumonectomy” and resections of the remaining lung after pneumonectomy [35,46]. For example, repeated resections on both sides with a subsequent pneumonectomy were performed in one patient along with 52 bronchoscopies . Lung resection or pneumonectomy was deemed permissible even in cases of severe respiratory insufficiency [45,46,50,51]. Bilateral resections or pneumonectomy plus contralateral “economic” (sparing) resection were regarded to be indicated for patients with a Tb lesion on one side and non-specific inflammatory and/or fibrotic lesion on the other side .
Several words should be said about bronchoscopy (Bs) that has been applied in all forms of Tb in children and adults also when Tb was suspected (references are in the preceding article ; it was recommended for young patients with “hyperergic” (high degree of hypersensitivity) tuberculin tests or within the diagnostic algorithm for suspected Tb in smear-negative cases [54,55]. After a detection of M. tuberculosis, an urgent hospitalization and examination including Bs is currently recommended . Primary Tb was regarded as an indication for Bs in children . Bs was designated as one of the main diagnostic methods for focal non-destructive Tb . In destructive (cavitary) Tb, repeated therapeutic Bs (1-2 weekly during 2-4 months) were recommended by the Ministry of Health . Bs was used as a screening tool for Tb in patients with general malaise, both with positive and negative tuberculin tests . Some researchers used Bs as a second step of screening for Tb in children . Therapeutic Bs and bronchoscopic monitoring has been applied in pulmonary Tb also with non-specific bronchial lesions [61-63]. For example, 22,469 Bs were performed in 5195 patients, including 1766 (34%) older than 65 years, at the Tb hospital No. 3 in Moscow (705-1225 beds at different times) from 1994 through 2013 . In particular, some military doctors performed many Bs e.g. 1478 procedures in 977 young (19.5 ± 0.1 years old) as well as in other patients diagnosed with community-acquired pneumonia [65-68].
Outside the former SU, Bs has not been routinely performed in all Tb patients . There is an opinion that in children Bs is usually unnecessary, although the procedure may be useful in diagnosing endobronchial TB [70,71]. Bs does not usually improve the microbiological diagnosis being not more sensitive for the culture than properly obtained gastric aspirates [70,72-75]. Endoscopic biopsy is a reliable sampling method for endobronchial Tb as well as for hilar and mediastinal lymph nodes. Bs is generally regarded to be indicated for patients with persistent cough, haemoptysis and signs of bronchostenosis such as wheezing and stridor . Bs is performed before surgery in Tb patients to rule out endobronchial disease at the proposed site of the bronchial stump . As endobronchial Tb may mimic neoplasms, Bs plays an important role to rule out cancer. In this connection, Bs is complementary to computed tomography (CT), which evaluates the bronchial involvement and luminal patency. In particular, the multiple detector CT with post-processing tools such as virtual bronchoscopy is an efficient diagnostic method for central airway lesions . Reportedly, CT depicted the cause of bleeding more frequently than Bs (77% vs. 8%, p < 0.001), whereas the two methods were comparable for identifying the site of bleeding . Some data suggested that CT can replace Bs e.g. as the firstline procedure for the screening patients with massive hemoptysis. Replacing Bs with induced sputum testing removes the risks from bronchoscopy including that of nosocomial infection . Of note, endoscopy is among the risk factors of nosocomial infections e.g. viral hepatitis , especially in conditions of suboptimal procedural quality assurance. Not surprisingly, the incidence of viral hepatitis (predominantly B) was reported to be 5 times higher in Tb patients than in the general population of Russia . Outbreaks of infections including Tb occurred after fiberoptic instruments were used [81-83]. Reportedly, Mycobacteria were the greatest obstacle to the infection control in Bs units . It has been suggested that Bs may spread infection within the lung, from one patient to another, and - by triggering coughing - cause airborne infection of other people . The use of Bs with questionable indications has been reviewed previously .
The surfactant (Sf) therapy of pulmonary diseases (Tb, acute respiratory distress syndrome, pneumonia etc.), excluding neonatal respiratory distress syndrome (RDS) with primary surfactant deficiency, and bronchoscopy as the delivery method have been discussed previously [85-88]. Sf-BL from bovine lungs has been developed and permitted for clinical use in Russia. The manufacturing method is described in the patent  (partly translated in [85,86], where it is noted that Sf-BL contains ~2% of protein. Endobronchial instillations of xenogeneic proteins may cause immune reactions and transmission of infection . In older patients, a more pronounced immune response can be expected than in premature infants with RDS. Endobronchial instillations of porcine Sf were accompanied by an augmentation of eosinophilic inflammation in patients with bronchial asthma . Rosenberg et al. used St-BL in asthma, bronchitis, pneumonia, chronic obstructive pulmonary diseases and Tb (more references are in the review and patent [89,92], as well as in COVID-19 , where immune and inflammatory reactions might contribute to the “cytokine storm” and collagen synthesis. Bs was used as the delivery method of Sf [92,94-101] with a biopsy of lung tissue in ; other studies used inhalations. Apart from inhalations, Bs was used within the framework of Sf research in Tb patients [101,102]. Sf-BL was recommended by a Letter of the Health Ministry for the treatment of viral (A/H1N1 influenza) pneumonia . This Letter refers to the manufacturer’s instruction No. 003383/01-230710, where it is stated that the optimal method of the Sf delivery is Bs with an instillation into individual segmental bronchi . No comparable recommendations have been found in the literature. Until recently, Oleg Rosenberg had been director of the manufacturing firm Biosurf (https://biosurf.ru/). No conflicts of interest have been declared in his publications. Rosenberg applied misquoting in his papers on Sf, specified in detail previously [87,88]. Some studies from Russia have reported that inhalations of Sf improve effectiveness of the anti-Tb therapy, significantly accelerating healing, dissolution of specific infiltrations and closing of caverns, while M. tuberculosis disappeared from sputum at an early date [89,102,105-107]. No similar reports have been found in the international literature. Finally, intravenous injections of stem cells to Tb patients should be mentioned together with the warning against unjustified use of Bs for such purposes as it has previously been done concerning intracoronary injections of cells obtained from the abortion material [108-112].
The treatment of patients suffering both of Tb and alcoholism needs a special comment. According to official instructions, indications for surgery were broader in alcoholics than in other Tb patients . In case of alcoholism, the surgical treatment was recommended earlier i.e. after a shorter period of medical therapy . Among other things, vocal cord injuries were observed after repeated Bs sometimes performed in conditions of suboptimal procedural quality assurance. It was noticed that vigorous apomorphine-induced vomiting as emetic or aversive therapy of alcoholism provoked hemoptysis . The following treatments were applied to alcoholics: prolonged intravenous infusions, sorbent hemoperfusion, endobronchial and endolymphatic drug delivery, pyrotherapy with sulfozine (oil solution of sulphur for intramuscular injections), endoscopic and surgical biopsies, sometimes without clear indications also for research [115-118]. Infusions for the purpose of detoxification were generally recommended for patients with alcohol dependence and alcoholism including moderately severe withdrawal syndrome [119-122]. The prescribed duration of detoxifying treatment was 10-12 days . This included intravenous drip infusions of solutions: sodium and calcium chloride, sodium thiosulfate, magnesium sulfate, glucose, dextran etc. (7-10 infusions daily, alternating with intramuscular injections). The latter is at variance with the international literature. Alcohol and its metabolites are eliminated spontaneously while rehydration can be normally achieved per os. Intravenous glucose and magnesium are generally not recommended for patients with alcohol withdrawal syndrome [123,124]. Excessive infusions of magnesiumcontaining solutions are associated with adverse effects also in treated alcoholics . Moreover, the detoxifying treatment of alcoholics included intramuscular injections of 10-15 ml of 25% magnesium sulfate solution together with 10 ml 40% glucose, 10 ml of 10% calcium chloride and 10 ml 30% sodium thiosulfate solutions, subcutaneous infusions of up to one liter of isotonic saline etc. [119,126,127] In conditions of suboptimal procedural quality assurance, repeated infusions, endovascular and endoscopic manipulations can lead to the transmission of viral hepatitis, which was known to occur to treated alcoholic patients.
The outpatient treatment of Tb patients, usual in other countries, was supposed to be hardly applicable in Russia . According to the governmental Ordinance No. 378 of 16 June 2006, patients with infectious Tb are not allowed to live in one apartment with other people. As per the Federal Law No. 77 “Prevention of the spread of Tb in Russia” of 18 June 2001 (amended 2013), “Patients with contagious forms of Tb, repeatedly violating the sanitary and antiepidemic regime, as well as those deliberately evading examinations for Tb or [emphasis added] the treatment of Tb, are hospitalized into phtisiological institutions for obligatory examination and treatment by court decisions.” It is stipulated by the same Law that the principle of informed consent is not applicable in this connection (Articles 7,9,10). A survey conducted across Russian phtisiological institutions found >6000 relevant trials in the period 2004-2008 whereas 3163 patients were hospitalized after court decisions . For example, in the study from Kemerovo province, 463 trials were reported resulting in 421 decisions of compulsory hospitalization of Tb patients . There are administrative and legal mechanisms e.g. hospitalization of Tb patients with the help of police and criminal prosecution in case of non-compliance. Among others, the latter pertains to non-contagious Tb patients released from prison .
The compulsory treatment was endorsed by regulations ; more details and references are in the review . Reportedly, in 1994 about 60% patients of one of the “phtisio-narcological” institutions for compulsory treatment escaped while a half of them were returned by the police (militia) . The duration of compulsory treatment in such institutions was around one year or longer . In 1974, chronic alcoholism was officially declared to be a ground for the compulsory treatment; the regulation was hardened in 1985, making the compulsory hospitalization and treatment of chronic alcoholics independent of anti-social behavior. This practice has been designated in 1990 as contradictory to the human rights . The system of compulsory treatment for Tb was partly dismantled during the 1990s; but some experts recommended its restoration and further development [129,130].
The surgical treatment of Tb is indicated for life-threatening conditions such as massive hemoptysis from cavitary disease or bronchiectasis. Adjuvant surgical therapy may be recommended for selected patients especially with multidrug resistant Tb; however, indications are rarely absolute [1,14,134]. The role of surgery remains controversial. Clinical recommendations are not the goal of this commentary. The message is that patients should not undergo surgeries and other invasive procedures to comply with instructions and doctrines fed by motives like personnel training, especially of military surgeons, endoscopists, etc., without sufficient evidencebased indications . The approach should be individual based on the consensus expressed in the recent international literature. The principle of informed consent must be observed - patients comprehensively informed on potential benefits and risks to be able to make an independent decision.
The principle of informed consent has not been uniformly adhered to in the former SU, which was facilitated by the widespread paternalistic attitude to patients. Informed consent started only recently to be mentioned in papers reporting research using invasive methods e.g. bronchoscopic study of childhood asthma, where the consent of parents was regarded to be sufficient . Note that the principle of informed consent or assent is applicable also to adolescents and children [136,137]. Even today, patients are sometimes requested to sign in advance a form certifying their blanket consent to unnamed diagnostic and therapeutic procedures. The factors contributing to the persistence of suboptimal practices included the authoritative management style, disregard for the rules of scientific polemics, insufficient use of the foreign literature and absence of many internationally used handbooks even in central medical libraries [138,139]. Thanks to the Internet, the foreign literature is used increasingly, while the practice is adjusted to international standards. However, some papers containing questionable recommendations have remained without due commentaries, so that persistence of suboptimal practices or reversion to them is not excluded. Other invasive procedures applied with questionable indications have been reviewed previously [33,53,140,141].
1. Fox GJ, Mitnick CD, Benedetti A, Chan ED, Becerra M, et al. (2016) Surgery as an adjunctive treatment for multidrug-resistant tuberculosis: an individual patient data meta analysis. Clin Infect Dis 62: 887-895.
2. WHO (2014) The role of surgery in the treatment of pulmonary tuberculosis and multidrug- and extensively drug-resistant tuberculosis. World Health Organization Regional Office for Europe, Geneva.
4. O N Ots, M V Sinitsyn, G I Semenov, A N Latyshev, T V Agkatsev, et al. (2009) Surgery for respiratory tuberculosis at the Research Institute of Phthisiopulmonology, I. M. Sechenov Moscow Medical Academy: history and current trends. Probl Tuberk Bolezn Legk 11-21.
6. Perelman MI, Streltsov VP, Naumov VN (1989) Clinical and social aspects of organ-preserving lung surgery in tuberculosis. In: Organ-preserving operations in phtisio-pulmonology. Scientific Center for Phthisio-Pulmonology, Moscow, 4-6 (in Russian).
7. M V Shilova, T S Khruleva, E B Tsybikova (2005) Surgical aid to patients with respiratory tuberculosis. Probl Tuberk Bolezn Legk (5): 31-36.
8. Kibrik BS, Bukharin PA (1976) Rehabilitation of patients following pulmonary resections for tuberculosis. Probl Tuberk 12: 43-47.
9. Kiseleva IA (1976) Clinical aspects and results of surgical treatment of metatuberculous changes of the lungs. Probl Tuberk 31-35.
10. Priimak AA (1989) Significance of surgical methods in the combined therapy of tuberculosis. In: Organ-preserving operations in phtisio-pulmonology. Scientific Center for Phthisio-Pulmonology, Moscow, 7-8 (in Russian).
11. Perel’man MI, Naumov VN, Dobkin VG, Strel’tsov VP, Dubrovskii AV (2002) Indication for the surgery in patients with pulmonary tuberculosis. Probl Tuberk 2: 51-55.
12. Motus IYa, Skorniakov SN, Golubev DN, Karskanova SS, et al. (2009) Surgical treatment of pulmonary tuberculosis. Journal of Ural Medical Academic Science 103-106.
13. Olcmen A, Gunluoglu MZ, Demir A, Akin H, Kara HV, et al. (2006) Role and outcome of surgery for pulmonary tuberculosis. Asian Cardiovasc Thorac Ann 14: 363-366.
14. Dewan RK, Pezzella AT (2016) Surgical aspects of pulmonary tuberculosis: an update. Asian Cardiovasc Thorac Ann 24: 835-846.
15. Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN et al. (2012) Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data metaanalysis of 9,153 patients. PLoS Med 9: e1001300.
16. Yablonskii PK, Kudriashov GG, Avetisyan AO (2019) Surgical resection in the treatment of pulmonary tuberculosis. Thorac Surg Clin 29: 37-46.
17. Roh HF, Kim J, Nam SH, Kim JM (2017) Pulmonary resection for patients with multidrug-resistant tuberculosis based on survival outcomes: a systematic review and meta-analysis. Eur J Cardiothorac Surg 52: 673-678.
18. Kempker RR, Vashakidze S, Solomonia N, Dzidzikashvili N, Blumberg HM (2012) Surgical treatment of drug-resistant tuberculosis. Lancet Infect Dis 12: 157-166.
19. Perelman MI (2006) Surgical treatment of pulmonary tuberculosis. In: Raviglione MC, editor. Reichman and Hershfield’s Tuberculosis. A comprehensive international approach. Third edition. Part A. Informa Healthcare USA, New York, 459-481 (Lung Biology in Health and Disease, Vol. 219).
20. Man MA, Nicolau D (2012) Surgical treatment to increase the success rate of multidrug-resistant tuberculosis. Eur J Cardiothorac Surg 42: e9-12.
21. Dewan R, Pasechnikov A (2013) Tuberculosis (TB) surgery guideline. Médecins Sans Frontières, Paris.
22. Wang H, Lin H, Jiang G (2008) Pulmonary resection in the treatment of multidrug-resistant tuberculosis: a retrospective study of 56 cases. Ann Thorac Surg 86: 1640-1645.
23. Pomerantz BJ, Cleveland J, Olsen H, Pomerantz M (2001) Pulmonary resection for multidrug resistant tuberculosis. J Thorac Cardiovasc Surg 121: 448-453.
24. Guidelines for the programmatic management of drug-resistant tuberculosis (2008) Emergency update 2008. World Health Organization, Geneva.
25. Giller DB, Martel II, Baryshnikova LA (2016) Surgery of tuberculosis in children. Aldi-Print, Moscow (in Russian).
27. Uspenskii LV, Romanychev IuA, Kodolova IM, Chistov LV, Ablitsov IuA (1986) Diagnosis and treatment of pulmonary tuberculomas. Khirurgiia (Mosk) 5: 11-15.
28. Gur’ianov VN, Strel’tsov VP, Al’ba MN (2000) Early surgical treatment of new restrictive forms of pulmonary tuberculosis. Probl Tuberk 6: 48-51.
29. Pilipchuk NS, Kharchenko EF, Ivaniuta OM (1974) Tuberculoma of the lungs, pleura and mediastinum. Zdorov’ia, Kiev (in Russian).
30. Valiev RS, Valiev NR, Iksanov IY, Filatova MS (2014) Epidemical importance of lung tuberculoma, the efficiency of their surgical and non-surgical treatment based on data from the Republic of Tatarstan. Probl Tuberk Bolezn Legk 4: 18-21.
32. Slepukha IM (1975) The use of surgical treatment of pulmonary tuberculosis in the age aspect. In: Problems of the lung surgery (to the 70th anniversary of Prof. Lev Konstantinovich Bogush). Central Institute of Tuberculosis, Moscow 127-134.
33. Jargin SV (2016) Surgical procedures with questionable indications: A letter from Russia. J Surg 4: 6.
34. Porkhanov VA, Mova VS, Poliakov IS, Grebennikov SV, Marchenko LG (1998) Surgical treatment of bilateral pulmonary tuberculosis. Probl Tuberk 1: 36-39.
35. Repin IuM (1990) Repeated pneumonectomy in recurrence of pulmonary tuberculosis. Probl Tuberk 12: 35-39.
36. Andrenko AA, Krasnov VA, Grishchenko NG (2000) Surgical treatment of patients with advanced bilateral destructive pulmonary tuberculosis. Probl Tuberk 3: 32-35.
37. Ots ON (2012) The surgical treatment of pulmonary tuberculosis with the resistance of mycobacteria to drugs. Sechenovskii Vestnik 2: 15-23.
38. Kubiak VA, Lakomkin MM, Martirosjan NL (2004) Abstract 196. The peculiarities of the surgical treatment of drug resistant pulmonary tuberculosis. In: Abstract book. 3rd Congress of European Region, International Union against Tuberculosis and Lung diseases (IUATLD), 14th National Congress of Lung diseases, Moscow, 55.
39. Zyskin LIu, Kozello NA, Grishin MN, Bereza RA (1991) Early operations in pulmonary tuberculosis. Probl Tuberk 36-38.
40. Voloshyn IaM (1999) The indications and contraindications for the use of lung resection for tuberculoma in a diabetic patient. Klin Khir 6: 13-15.
41. Voloshyn IaM, Podhaievs'kyi SG, Kovalenchenko VF (1999) Clinical course, diagnosis and specific features of treatment of pulmonary tuberculoma in patients with diabetes mellitus. Klin Khir 2: 25-27.
43. Sokolov EA (1978) Surgical treatment of pulmonary tuberculosis patients over 60. Probl Tuberk 7: 23-27.
44. Sokolov SB (1975) Surgical treatment of aged tuberculosis patients. In: Problems of the lung surgery (to the 70th anniversary of Prof. Lev Konstantinovich Bogush). Central Institute of Tuberculosis, Moscow 103-110 (in Russian).
45. Bogush LK, Kariev TM, Eshankhanov M (1983) Surgery of severe forms of pulmonary tuberculosis. Meditsina, Tashkent (in Russian).
46. Korneevskii MD (1975) Bilateral lung resections in tuberculosis patients. In: Problems of the lung surgery (to the 70th anniversary of Prof. Lev Konstantinovich Bogush). Central Institute of Tuberculosis, Moscow, pp. 376-384 (in Russian).
48. El’kin AV, Repin IuM, Levashev IuN (2004) Surgical treatment for postoperative recurrent pulmonary tuberculosis. Probl Tuberk Bolezn Legk 28-32.
49. Kravchenko AF, Vinokurov II, Ivanov IuS, O-zhi-kho EA (2003) A case of multiple operations in pulmonary tuberculosis. Probl Tuberk Bolezn Legk 48-49.
50. Naumov VN, Karaeva GB (1993) Surgical treatment of patients with disseminated and progressing pulmonary tuberculosis. Probl Tuberk 23-26.
51. Bogush LK, Kalinichev GA (1979) Correcting operations at lung resections. Sabchota Sakartvelo, Tbilisi (in Russian).
52. Niiazov IB (1976) Bilateral resection in patients with tuberculosis associated with nonspecific lung diseases. Probl Tuberk 29-31.
54. Chelidze AV, Chernousova TIa, Karpukhina NV, Khorosheva MN, Moiseenko LM (1982) Bronchial status in children, adolescents and young people with elevated tuberculin sensitivity. Probl Tuberk 9: 27-30.
55. Palamarchuk GF, Akopov AL, Arseniev AI, Derevianko AV, Nagornaya OA (2019) Bronchoscopy in the diagnosis and treatment of respiratory diseases. Foliant, Saint Petersburg (in Russian).
57. Kostina ZI, Balashova NM, Balakireva AI, Gerasimova EV, Ivanovskii VB (1987) Value of various methods of the diagnosis of focal pulmonary tuberculosis. Probl Tuberk 11: 28-32.
58. 58. Methodical Recommendations (1982) Endobronchial methods of tuberculosis treatment. Ministry of Health of RSFSR, Moscow (in Russian).
59. Belen’ki MS (1962) Diagnosis of chronic tuberculosis intoxication on adults. Dissertation, Kharkov Medical Institute (in Russian).
60. Aksenova VA, Rozinova NN, Mokhnachevskaia AI, Kravchenko AF (2005) Detection of tuberculosis in children and adolescents with non-specific pulmonary pathology in public health institutions. Sechenov Medical Academy, Moscow (in Russian).
61. Berzner AN, German AK, Kovalenbko BA, Kostrub LA, Li BP (1988) Treatment effectiveness in intrathoracic tuberculosis in children and adolescents and the characteristics of the residual posttuberculosis changes. Probl Tuberk 32-34.
62. Filippov VP, Chernichenko NV (2014) Bronchoscopy in pulmonary diseases. Binom, Moscow (in Russian).
63. Chernekhovskaia NE, Andreev VG, Povaliaev AV (2011) Therapeutic bronchoscopy in the complex therapy of respiratory organs. 2nd edition. Medpress-inform, Moscow (in Russian).
64. Svistunov BD, Svistunova AS (2015) Endoscopic technologies in phthisiology. Tuberkulez i socialno znachmye zabolevania 25-28.
65. Kazantsev VA (2004) Abstract 1358. The use of bronchological sanation for treatment of community-acquired pneumonia. In: Abstract book. 3rd Congress of European Region, International Union against Tuberculosis and Lung diseases (IUATLD), 14th National Congress of Lung diseases, Moscow, 361.
66. Iakovlev GM, Kazantsev VA (1987) Clinico-immunological characteristics and prevention of recurrent acute pneumonias. Voen Med Zh 38-39.
67. Iakovlev GM, Kazantsev VA (1988) Clinico-immunological characteristics of acute pneumonia in young patients. Ter Arkh 60: 57-60.
68. Rakov AL, Komarevtsev VN, Kharitonov MA, Kazantsev VA (2005) Characteristics of community-acquired pneumonia in servicemen during the military conflict on the Northern Caucasus in 1995-1996. Voen Med Zh 326: 23-30.
69. Mondoni M, Repossi A, Carlucci P, Centanni S, Sotgiu G (2017) Bronchoscopic techniques in the management of patients with tuberculosis. Int J Infect Dis 64: 27-37.
70. Khan EA, Starke JR (1995) Diagnosis of tuberculosis in children: increased need for better methods. Emerg Infect Dis 1: 115-123.
73. McIntosh N, Helms PJ, Smyth RL (2004) Forfar & Arneil's textbook of pediatrics: 6th edition. J R Soc Med 97: 96.
74. Tagarro García A, Barrio Gómez de Agüero MI, Martínez Carrasco C, Antelo Landeira C, Díez Dorado R, del Castillo F, et al. (2004) Fibrobroncoscopia en la tuberculosis endobronquial. Ann Pediatr (Barc) 61: 314-319.
75. Donato L, Helms P, Barats A, Lebris V (2005) Endoscopie bronchique et tuberculose de l'enfant. Arch Pediatr 12 Suppl 2: 127-131.
76. Barnes D, Gutiérrez Chacoff J, Benegas M, Perea RJ, de Caralt TM, Ramirez J, et al. (2017) Central airway pathology: clinic features, CT findings with pathologic and virtual endoscopy correlation. Insights Imaging 8: 255-270.
77. Revel MP, Fournier LS, Hennebicque AS, Cuenod CA, Meyer G, Reynaud P, Frija G (2002) Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis? AJR Am J Roentgenol 179: 1217-1224.
78. McWilliams T, Wells AU, Harrison AC, Lindstrom S, Cameron RJ, Foskin E (2002) Induced sputum and bronchoscopy in the diagnosis of pulmonary tuberculosis. Thorax 57: 1010-1014.
79. Barut S, Erkorkmaz U, Yüce S, Uyetürk U (2008) Analysis of risk factors in anti-HCV positive patients in Gaziosmanpasa University Hospital, Tokat, Turkey. Mikrobiyol Bul 42: 675-680.
80. Kulakova AV, Kokina NI, Kogan EA, Ablitsov YuM, Pavlov ChS, (2004) Abstract 46. Peculiarities of therapy in patients with tuberculosis associated to viral hepatitis. In: Abstract book. 3rd Congress of European Region, International Union against Tuberculosis and Lung diseases (IUATLD), 14th National Congress of Lung diseases, Moscow 16.
81. Larson JL, Lambert L, Stricof RL, Driscoll J, McGarry MA, Ridzon R (2003) Potential nosocomial exposure to Mycobacterium tuberculosis from a bronchoscope. Infect Control Hosp Epidemiol 24: 825-830.
82. Ramsey AH, Oemig TV, Davis JP, Massey JP, Török TJ (2002) An outbreak of bronchoscopy-related Mycobacterium tuberculosis infections due to lack of bronchoscope leak testing. Chest 121: 976-981.
83. Hanson PJ, Jeffries DJ, Batten JC, Collins JV (1988) Infection control revisited: dilemma facing today's bronchoscopists. BMJ 297(6642): 185-187.
84. Mehta AC, Minai OA (1999) Infection control in the bronchoscopy suite. A review. Clin Chest Med 20: 19-32.
85. Jargin SV (2012) Surfactant preparations for tuberculosis and other diseases beyond infancy: a letter from Russia. Tuberculosis (Edinb) 92: 280-282.
86. Jargin SV (2013) Surfactant therapy of pulmonary conditions excluding those with primary surfactant deficiency and bronchoscopy as delivery method: an overview of Russian patents and publications. Recent Pat Drug Deliv Formul 7: 134-137.
87. Jargin SV (2021) The use of surfactant preparations in the absence of primary deficiency: publications, legal and regulatory framework. GlavVrach 1: 40-51.
88. Jargin SV (2013) Pulmonary surfactant preparations in the absence of its primary deficiency: a physicist’s view (in Russian). Molodoi Uchenyi - Young Scientist 5: 870-873.
89. Rozenberg OA, Seiliev AA (2019) Method for obtaining surfactant from bovine lungs. Patent RU2691648C1.
90. Fujiwara T, Robertson B (1992) Pharmacology of exogenous surfactant. In: Robertson B, van Golde LMG, Batenburg JJ, eds. Pulmonary surfactant. From molecular biology to clinical practice. Elsevier, Amsterdam, 561-592.
91. Erpenbeck VJ, Hagenberg A, Dulkys Y, Elsner J, Bälder R, Krentel H, et al. (2004) Natural porcine surfactant augments airway inflammation after allergen challenge in patients with asthma. Am J Respir Crit Care Med 169: 578-586.
92. Rozenberg OA (2019) Pulmonary surfactant preparations and surfactant therapy for ards in surgical intensive care (a literature review). Creative Surgery and Oncology 9: 50-65.
93. Bautin AE, Avdeev SN, Seyliev AA, Shvechkova MV, Merzhoeva ZM, Trushenko NV, et al. (2020) Inhalation surfactant therapy in the integrated treatment of severe COVID-19 pneumonia. Tuberk Bolezn Legk 98: 6-12.
94. Granov AM, Rozenberg OA, Tsybul'kin EK, Erokhin VV, Khubulava GG, et al. (2001) Critical state medicine. Surfactant therapy of adult respiratory distress syndrome (results of multicenter studies). Vestn Ross Akad Med Nauk (5): 34-38.
95. Bautin A, Khubulava G, Kozlov I, Poptzov V, Osovskikh V, et al. (2006) Surfactant therapy for patients with ARDS after cardiac surgery. J Liposome Res 16: 265-272.
96. Tsybul'kin EK, Rozenberg OA, Seiliev AA, Volchkov VA, Zaitseva NV, et al. (1999) Our experience in the use of a Russian preparation of pulmonary surfactant in the treatment of acute respiratory distress syndrome and severe pneumonia in children. Anesteziol Reanimatol 61-65.
97. Bautin AE, Khubulava GG, Fadeev AA, Rozenberg OA (2003) The first experience with using a preparation of lung surfactant for prevention and treatment of the acute lung injury syndrome after operations on the heart and aorta. Vestn Khir Im I I Grek 162: 79-83.
98. Kozlov IA, Poptsov VN (2005) Surfactant-BL and inhaled nitric oxide in acute respiratory distress syndrome in cardiac surgical patients. Anesteziol Reanimatol 38-41.
99. Kozlov IA, Poptsov VN (2005) Combined therapy with nitric oxide and Surfactant-BL for acute respiratory distress syndrome after operations using extracorporeal circulation. Obshtshaia Reanimatologiia 1: 15-9.
100. Pochepen ON, Zolotuhina LV, Zemec EA, Markevich MN, Troyanovskiy ES (2011) The use of Surfactant-BL in treatment of inhalation injury after severe burns. Skoraia Meditsinskaia Pomoshtsh 12: 44-47.
101. Lepekha LN (1995) Pulmonary surfactant system in experimental tuberculous inflammation and evaluation of its morpho-functional condition in humans. Doctoral dissertation. Research Institute of Human Morphology, Moscow (in Russian).
102. Lovacheva OV, Erokhin VV, Chernichenko NV, Evgushchenko GV, Lepekha LN, et al. (2006) Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis. Probl Tuberk Bolezn Legk 12-17.
103. Ministry of Health of Russian Federation (2009) A/H1N1 influenza and the corresponding pneumonia in pregnant women. Etiotropic and respiratory therapy. Information letter Nr. 24-5/10/2-9533 of November 28, 2009.
105. Zhemkov VF, Ivanovsky VB, Zhemkova MV, Seiliev AA, Volchkov VA, Rozenberg OA (2013) Use of natural lung surfactant in the combination treatment of pulmonary tuberculosis. Probl Tuberk Bolezn Legk 18-22.
106. Erokhin VV, Lepekha LN, Erokhina MV, Lovacheva OV (2013) The surfactant system in pulmonary tuberculosis. Central Tuberculosis Research Institute, Moscow (in Russian).
107. Erokhin VV, Lovacheva OV, Lepekha LN, Rozenberg OA, Seiliev AA, Volchkov VA (2002) Pulmonary tuberculosis treatment method. Patent RU2195313C1.
108. Erokhin VV, Vasil'eva IA, Konopliannikov AG, Chukanov VI, Tsyb AF, et al. (2008) Systemic transplantation of autologous mesenchymal stem cells of the bone marrow in the treatment of patients with multidrug-resistant pulmonary tuberculosis. Probl Tuberk Bolezn Legk 3-6.
109. Erokhin VV, Tsyb AF, Chukanov VI, Vasil'eva IA, Bagdasarian TR, et al. (2006) Cellular technologies in therapy for chronic multidrug-resistant pulmonary tuberculosis. Probl Tuberk Bolezn Legk 3-5.
110. Kirillov AM, Fatkhudinov TKh, Dyachkov AV, Koroteev AV, Goldshtein DV, et al. (2007) Transplantation of allogenic cells in the therapy of patients with dilated cardiomyopathy. Bull Exp Biol Med 144: 635-639.
111. Fatkhutdinov TKh, D'yachkov AV, Koroteyev AV, Goldstein DV, Bochkov NP (2010) Safety and efficiency of transplantation of allogenic multipotent stromal cells in surgical treatment of dilatated cardiomyopathy. Bull Exp Biol Med 149: 119-124.
113. Methodical Recommendations (1987) Special features of detection, diagnosis, clinical course, treatment and prevention of tuberculosis in patients with chronic alcoholism. Health Ministry of Ukrainian SSR, Kiev (in Russian).
115. Methodical Recommendations (1989) Combined treatment of patients with pulmonary tuberculosis suffering of alcoholism. Health Ministry of RSFSR, Moscow (in Russian).
116. Makhov VM, Abdullin RG, Gitel' EL, Zavodnov VIa, Podzolkov VI, et al (1996) Visceral lesions in alcoholism. Ter Arkh 68: 53-56.
117. Krut’ko VS (1990) Pneumonia in patients with pulmonary tuberculosis and alcoholism. Probl Tuberk 64-66.
118. Jargin SV (2016) Alcohol abuse and toxicity of alcoholic beverages in Russia: Recent history. ARC Journal of Addiction 1: 21-29.
119. Methodical Recommendations (1989) Combined treatment of patients with pulmonary tuberculosis suffering of alcoholism. Health Ministry of RSFSR, Moscow (in Russian).
123. Jesse S, Bråthen G, Ferrara M, Keindl M, Ben-Menachem E, et al. (2017) Alcohol withdrawal syndrome: mechanisms, manifestations, and management. Acta Neurol Scand 135: 4-16.
124. Schuckit MA (2014) Recognition and management of withdrawal delirium (delirium tremens). N Engl J Med 371: 2109-2113.
126. Methodical Recommendations (1987) Special features of detection, diagnosis, clinical course, treatment and prevention of tuberculosis in patients with chronic alcoholism. Health Ministry of Ukrainian SSR, Kiev (in Russian).
128. Bogadel’nikova IV, Sagalovich VIa, Perel’man MI (2000) The efficacy of the ambulatory treatment of patients with newly detected pulmonary tuberculosis. Probl Tuberk 23-28.
129. Bogorodskaia EM, Ol’khovatskii EM, Borisov SE (2009) Legal aspects of compulsory hospitalization of incompliant patients with tuberculosis. Probl Tuberk Bolezn Legk 8-14.
130. Lomova LA, Kopylova IF, Smerdin SV, Chernov MT, Baeva LB, et al. (2009) Compulsory hospitalization of non-compliant patients with tuberculosis. Tuberk Biolezni Legkih 9-13.
131. Trifonova NIu (2010) Medical and organizational approaches to the quality enhancement of dispensary monitoring of tuberculosis patients in present conditions. IKAR, Moscow (in Russian).
132. Rudoi NM, Dzhokhadze VA, Chubakov TCh, Stadnikova AV (1994) Current status and perspectives in hospital treatment of patients with tuberculosis complicated with alcohol abuse. Probl Tuberk 8-10.
133. Grishko AIa (1991) The institute of compulsory treatment and occupational re-education of chronic alcoholics and drug addicts, its social purpose. Academy of the Ministry of Internal Affairs, Moscow (in Russian).
134. Calligaro GL, Moodley L, Symons G, Dheda K (2014) The medical and surgical treatment of drug-resistant tuberculosis. J Thorac Dis 6: 186-195.
135. Fedorov IA, Wilson SJ, Davies DE, Holgate ST (2005) Epithelial stress and structural remodelling in childhood asthma. Thorax 60: 389-394.
136. Neill SJ (2005) Research with children: a critical review of the guidelines. J Child Health Care 9: 46-58.
137. Kuther TL, Posada M (2004) Children and adolescents’ capacity to provide informed consent for participation in research. Adv Psychol Res 32: 163-173.
138. Murphy J, Jargin S (2017) International trends in health science librarianship part 20: Russia. Health Info Libr J 34: 92-94.
139. Jargin SV (2020) Einige Aspekte des russischen medizinischen Bibliothekswesens. GMS Med Bibl Inf 20: 03.
140. Jargin SV (2014) Renal biopsy for research: an overview of Russian experience. J Interdiscipl Histopathol 2: 88-95.